Abstract
Alopecia areata (AA) is an autoimmune disorder that causes nonscarring hair loss and significantly impacts quality of life, particularly in pediatric patients. Since the early 2000s, AA severity has been evaluated using the Severity of Alopecia Tool (SALT), which quantifies scalp hair loss. However, recent advancements in the assessment tools provide a more comprehensive evaluation of AA, which is important for both measuring improvement during clinical trials and for a more holistic assessment in routine care. This review examines the development and implementation of assessment tools for AA, including newer tools that incorporate findings beyond the scalp, psychosocial impact, and chronicity. Through these tools, clinicians can gain a more detailed understanding of the multifaceted impact of AA, leading to improved individualized treatment strategies and advancing research in pediatric dermatology.
Original language | English (US) |
---|---|
Pages (from-to) | 31-35 |
Number of pages | 5 |
Journal | Pediatric dermatology |
Volume | 42 |
Issue number | S1 |
DOIs | |
State | Published - Mar 2025 |
Funding
Funding: Publication of this article is made possible by an educational grant from Pfizer
Keywords
- SALT
- alopecia areata
- clinical research
- hair loss
- psychosocial
- severity
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Dermatology